3,4-methylenedioxyamphetamine has been researched along with Cerebral Ischemia in 3 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhu, HY | 1 |
Bin, J | 2 |
Wang, C | 1 |
Lin, HB | 1 |
Zhou, H | 1 |
Xu, JP | 2 |
Wang, Q | 1 |
Zhuo, YY | 1 |
Zhang, HT | 1 |
Teggin, AF | 1 |
3 other studies available for 3,4-methylenedioxyamphetamine and Cerebral Ischemia
Article | Year |
---|---|
[Effects of piperphentonamine hydrochloride on cognitive deficits in rats induced by cerebral ischemia-reperfusion].
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Ischemia; Cognition Disorders; Infarction, Middle Cere | 2011 |
Piperphentonamine (PPTA) attenuated cerebral ischemia-induced memory deficits via neuroprotection associated with anti-apoptotic activity.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Apoptosis; Avoidance Learning; Brain Ischemia; CA1 Region, H | 2012 |
Ecstasy--a dangerous drug.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amitriptyline; Brain Ischemia; Depressive Disorder; Designer D | 1992 |